Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysis

Abstract Background Brugada syndrome (BrS) is a rare cardiac channelopathy linked to an increased risk of ventricular arrhythmias (VA) and sudden cardiac death. Radiofrequency ablation (RFA), particularly epicardial ablation, is recommended for BrS patients with recurrent VA unresponsive to conventi...

Full description

Saved in:
Bibliographic Details
Main Authors: Arga Setyo Adji MD, Atiyatum Billah MD, Juliardi Eka Putra Sit MD, Bryan Gervais deLiyis MD, Angga Nugraha MD, Angela Puspita MD, FICEP, Abdillah Maulana Satrioaji MD, Ragil Nur Rosyadi MD, FIHA
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Journal of Arrhythmia
Subjects:
Online Access:https://doi.org/10.1002/joa3.70073
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849430329952043008
author Arga Setyo Adji MD
Atiyatum Billah MD
Juliardi Eka Putra Sit MD
Bryan Gervais deLiyis MD
Angga Nugraha MD
Angela Puspita MD, FICEP
Abdillah Maulana Satrioaji MD
Ragil Nur Rosyadi MD, FIHA
author_facet Arga Setyo Adji MD
Atiyatum Billah MD
Juliardi Eka Putra Sit MD
Bryan Gervais deLiyis MD
Angga Nugraha MD
Angela Puspita MD, FICEP
Abdillah Maulana Satrioaji MD
Ragil Nur Rosyadi MD, FIHA
author_sort Arga Setyo Adji MD
collection DOAJ
description Abstract Background Brugada syndrome (BrS) is a rare cardiac channelopathy linked to an increased risk of ventricular arrhythmias (VA) and sudden cardiac death. Radiofrequency ablation (RFA), particularly epicardial ablation, is recommended for BrS patients with recurrent VA unresponsive to conventional treatments like implantable cardioverter‐defibrillators (ICD) and quinidine. This study aims to evaluate the long‐term efficacy of epicardial RFA in preventing VA recurrence in BrS. Methods A systematic search of PubMed, ScienceDirect, Cochrane Library, and ProQuest databases was conducted following PRISMA 2020 guidelines. Studies on RFA for VA in BrS were included. Primary outcomes were VA recurrence and all‐cause mortality. Statistical analysis was performed using Review Manager 5.4. Results Epicardial, endocardial, and combined ablation strategies effectively reduced VA recurrence, decreased ICD shocks, and improved clinical outcomes in BrS. Epicardial ablation RFA near coronary arteries showed a notable reduction in VA recurrence, while endocardial ablation remained a viable alternative. Meta‐analysis revealed a significant reduction in VA recurrence (RR 0.17; 95% CI 0.07–0.43; p < .0001) and ICD shocks (RR 0.13; 95% CI 0.04–0.44; p = .001). Subgroup analysis suggested greater VA reduction with epicardial ablation, though without statistical significance. Conclusion Epicardial RFA is associated with a significant reduction in recurrent VAs (83%) and ICD shock rates (87%) in patients with BrS. The procedure demonstrates a favorable long‐term safety profile, with no mortality reported in the included studies.
format Article
id doaj-art-d556e8070cb04fb7a97db81fc749c92e
institution Kabale University
issn 1880-4276
1883-2148
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series Journal of Arrhythmia
spelling doaj-art-d556e8070cb04fb7a97db81fc749c92e2025-08-20T03:28:01ZengWileyJournal of Arrhythmia1880-42761883-21482025-06-01413n/an/a10.1002/joa3.70073Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysisArga Setyo Adji MD0Atiyatum Billah MD1Juliardi Eka Putra Sit MD2Bryan Gervais deLiyis MD3Angga Nugraha MD4Angela Puspita MD, FICEP5Abdillah Maulana Satrioaji MD6Ragil Nur Rosyadi MD, FIHA7Faculty of Medicine Hang Tuah University Surabaya East Java IndonesiaFaculty of Medicine Hang Tuah University Surabaya East Java IndonesiaFaculty of Medicine Hang Tuah University Surabaya East Java IndonesiaFaculty of Medicine Udayana University Denpasar Bali IndonesiaDepartment of Cardiology, Gadjah Mada University, Yogyakarta, Center Java, Indonesia Yogyakarta Center Java IndonesiaEmergency Medicine Division, Department of Internal Medicine Hang Tuah University Surabaya East Java IndonesiaFaculty of Medicine Hang Tuah University Surabaya East Java IndonesiaDepartment of Cardiology Rumah Sakit Pusat Angkatan Laut Dr. Ramelan Surabaya East Java IndonesiaAbstract Background Brugada syndrome (BrS) is a rare cardiac channelopathy linked to an increased risk of ventricular arrhythmias (VA) and sudden cardiac death. Radiofrequency ablation (RFA), particularly epicardial ablation, is recommended for BrS patients with recurrent VA unresponsive to conventional treatments like implantable cardioverter‐defibrillators (ICD) and quinidine. This study aims to evaluate the long‐term efficacy of epicardial RFA in preventing VA recurrence in BrS. Methods A systematic search of PubMed, ScienceDirect, Cochrane Library, and ProQuest databases was conducted following PRISMA 2020 guidelines. Studies on RFA for VA in BrS were included. Primary outcomes were VA recurrence and all‐cause mortality. Statistical analysis was performed using Review Manager 5.4. Results Epicardial, endocardial, and combined ablation strategies effectively reduced VA recurrence, decreased ICD shocks, and improved clinical outcomes in BrS. Epicardial ablation RFA near coronary arteries showed a notable reduction in VA recurrence, while endocardial ablation remained a viable alternative. Meta‐analysis revealed a significant reduction in VA recurrence (RR 0.17; 95% CI 0.07–0.43; p < .0001) and ICD shocks (RR 0.13; 95% CI 0.04–0.44; p = .001). Subgroup analysis suggested greater VA reduction with epicardial ablation, though without statistical significance. Conclusion Epicardial RFA is associated with a significant reduction in recurrent VAs (83%) and ICD shock rates (87%) in patients with BrS. The procedure demonstrates a favorable long‐term safety profile, with no mortality reported in the included studies.https://doi.org/10.1002/joa3.70073Brugada syndromeepicardial radiofrequency ablationICD shocklong‐term outcomesventricular arrhythmia
spellingShingle Arga Setyo Adji MD
Atiyatum Billah MD
Juliardi Eka Putra Sit MD
Bryan Gervais deLiyis MD
Angga Nugraha MD
Angela Puspita MD, FICEP
Abdillah Maulana Satrioaji MD
Ragil Nur Rosyadi MD, FIHA
Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysis
Journal of Arrhythmia
Brugada syndrome
epicardial radiofrequency ablation
ICD shock
long‐term outcomes
ventricular arrhythmia
title Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysis
title_full Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysis
title_fullStr Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysis
title_full_unstemmed Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysis
title_short Long‐term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta‐analysis
title_sort long term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in brugada syndrome a systematic review and meta analysis
topic Brugada syndrome
epicardial radiofrequency ablation
ICD shock
long‐term outcomes
ventricular arrhythmia
url https://doi.org/10.1002/joa3.70073
work_keys_str_mv AT argasetyoadjimd longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis
AT atiyatumbillahmd longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis
AT juliardiekaputrasitmd longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis
AT bryangervaisdeliyismd longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis
AT angganugrahamd longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis
AT angelapuspitamdficep longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis
AT abdillahmaulanasatrioajimd longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis
AT ragilnurrosyadimdfiha longtermofepicardialradiofrequencyablationandbenefitforrecurrentventriculararrhythmiainbrugadasyndromeasystematicreviewandmetaanalysis